Eli Lilly & Co.’s stock rose 1.6% Wednesday, after the drug company announced plans to expand its U.S. manufacturing sites by adding four more locations this year, along with 13,000 high-wage jobs.

Tom Cruise and Ana de Armas made a second joint public appearance, one month after they first sparked romance rumors when ...

A new high-profile event dedicated to global TV series is being launched in Italy with “Bridgerton” star Adjoa Andoh, Evangeline Lilly (“Lost”) and Italy’s ‘Godfather of Disco ...

That negative investor reaction was directed at companies involved in the white-hot weight loss drug segment of the market (Eli Lilly is the pharmaceutical giant behind a popular one, Zepbound).

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of ...

Earlier this week, Eli Lilly partnered up with telehealth providers LifeMD and Teladoc Health to offer its lower cost, single-vial Zepbound (tirzepatide) to patients in the virtual care companies ...

A federal court in Texas has rejected a request by producers of compounded drugs to extend their ability to manufacture knockoff versions of Eli Lilly's tirzepatide while a lawsuit plays out.

Evangeline Lilly attends the Los Angeles Global Premiere for Marvel Studios' 'Ant-Man and The Wasp' at the El Capitan Theatre on June 25, 2018 in Hollywood, California. (Image Source: Getty Images for ...

Eli Lilly (LLY) ended the recent trading session at $912.76, demonstrating a -1.82% swing from the preceding day's closing price. The stock's performance was behind the S&P 500's daily loss of 1.78%.